The Yale Secret Shopper Study, Full Breakdown: 45 of 49 Sites Failed the Basics
This is the study that defines our mission. A JAMA-published secret shopper investigation sent researchers posing as patients to 49 telehealth GLP-1 platforms in early July 2026. Here's the full breakdown.
What researchers actually did
Trained researchers submitted standardized patient profiles to each platform, then evaluated the rigor of clinical review before a prescription was approved — specifically whether a licensed clinician engaged with the specific answers submitted, or whether approval happened largely automatically.
What separated the 4 that passed
What the successful platforms had in common
- Documented, individualized clinician review before approval
- Follow-up questions triggered by specific intake answers, not a uniform process regardless of input
- A defined monitoring plan beyond the initial prescription
Sesame Care From $29
A licensed physician network with documented individualized review.
Embody GLP1 From consult
Injectable semaglutide with documented clinical review as part of standard process.
Paid linkWhat to do with this information
Use our verification tool before committing to any provider, and ask directly whether a clinician will individually review your specific intake — not just whether "licensed clinicians" are involved somewhere in the process.